UniSa - IRIS Institutional Research Information System

ALTIERI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.528
AS - Asia 4.789
EU - Europa 2.158
SA - Sud America 190
Continente sconosciuto - Info sul continente non disponibili 87
AF - Africa 44
OC - Oceania 5
AN - Antartide 1
Totale 12.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.369
HK - Hong Kong 2.833
SG - Singapore 864
IT - Italia 610
CN - Cina 607
UA - Ucraina 399
DE - Germania 395
RU - Federazione Russa 337
VN - Vietnam 217
BR - Brasile 143
CA - Canada 116
FR - Francia 100
IE - Irlanda 96
KR - Corea 96
FI - Finlandia 92
IN - India 42
GB - Regno Unito 30
MX - Messico 26
SE - Svezia 26
TR - Turchia 24
AR - Argentina 18
NL - Olanda 18
BD - Bangladesh 15
JP - Giappone 13
ZA - Sudafrica 13
PL - Polonia 12
IQ - Iraq 11
ES - Italia 10
EU - Europa 10
PK - Pakistan 9
CO - Colombia 8
UZ - Uzbekistan 8
ID - Indonesia 6
JO - Giordania 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 6
VE - Venezuela 6
GR - Grecia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
IR - Iran 3
JM - Giamaica 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
KG - Kirghizistan 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
MT - Malta 1
MU - Mauritius 1
NE - Niger 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
Totale 12.716
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.828
Ann Arbor 817
Singapore 503
Jacksonville 477
San Jose 432
Chandler 406
Princeton 333
Milan 279
Ashburn 225
Dallas 211
Beijing 113
Wilmington 101
Council Bluffs 97
Dublin 97
Ottawa 92
Andover 90
Lauterbourg 88
Nanjing 86
Nürnberg 86
Boardman 76
Dong Ket 76
Woodbridge 76
The Dalles 74
Rome 69
Ho Chi Minh City 54
Pellezzano 54
Houston 40
Fairfield 39
Jinan 36
Changsha 35
Shenyang 35
Munich 34
Santa Clara 31
Hanoi 28
Los Angeles 25
Hebei 24
Jiaxing 24
Tianjin 24
São Paulo 22
Naples 21
New York 21
Nanchang 20
Figino 18
Brooklyn 17
Pune 17
San Francisco 17
Seattle 17
Zhengzhou 17
Turin 16
Norwalk 15
Orem 15
Salerno 14
Mexico City 13
Moscow 13
Redwood City 13
Chicago 12
Izmir 11
Atlanta 10
Guangzhou 10
Johannesburg 10
Columbus 9
Hangzhou 9
Montreal 9
Nuremberg 9
San Diego 9
Vietri Sul Mare 9
Warsaw 9
Amsterdam 8
Boston 8
Cambridge 8
Da Nang 8
Düsseldorf 8
Phoenix 8
Tashkent 8
Tokyo 8
Baghdad 7
Chennai 7
Frankfurt am Main 7
Haiphong 7
Ningbo 7
Stockholm 7
Turku 7
Amman 6
Hải Dương 6
Mountain View 6
Taiyuan 6
Taizhou 6
London 5
Mestre 5
Rio de Janeiro 5
Toronto 5
Baiano 4
Charlotte 4
City of London 4
Denver 4
Edinburgh 4
Fort Worth 4
Goiânia 4
Guardia Sanframondi 4
Helsinki 4
Totale 8.816
Salva come PNG Salva come JPEG
Nome #
Modulation of BAG3 expression in human normal urothelial cells by Diuron 1.072
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: Prognostic indicators of disease-specific survival 889
Amelanotic Malignant Melanoma of the Male Urethra: A Potential Diagnostic Pitfall 532
Ultrasonographic evaluation of urethrovesical junction mobility: correlation with type of delivery and stress urinary incontinence 422
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 369
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 367
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol 359
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma 245
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma 240
Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study 174
Choroidal evaluation in patients under alpha-lytic therapy 153
A randomised study evaluating maintenance schedule in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer 140
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer 139
A serum metabolomic signature for the detection and grading of bladder cancer 137
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 135
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 133
The best prostate biopsy sampling system—fusion and systematic biopsy: A single center experience 128
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. 127
Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report 125
Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens 124
Can pT2 classification for renal cell carcinoma be improved? An international multicenter experience? 124
Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17 123
Prognostic relevance of tumour size in T3a renal cell carcinoma: A multicentre experience 121
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas 121
["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience]. 119
A randomized trial comparing tamoxifen therapy vs. Tamoxifen prophylaxis in bicalutamide-induced gynecomastia 119
Proposal for revision of the TNM classification system for renal cell carcinoma 118
Altered expression of specific genes in the HOX network is associated with human bladder transitional cell carcinomas 117
A nomogram predicting renal cell carcinoma-specific survival in patients with nodal metastases is more accurate than any individual variable 115
KPNA2/ERG Coexpression is Associated with Early Recurrence in Advanced Prostate Cancers 115
PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells 112
Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study 110
[The Rokitansky-Kuster-Hauser syndrome with chromosome XO/XX mosaicism (single pelvic kidney)]. 110
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma 106
Prostate Health Index (phi) Is Able To Discriminate Benign and Precancerous Conditions From Prostate Cancer 104
[Imaging diagnosis of non-lymph node metastasis of bladder carcinoma]. 104
[Erectile dysfunction in kidney transplanted patients]. 104
Evaluation of expression of chromatin assembly factor-1 (CAF-1) p60 in prostatic preneoplastic lesions 102
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer 101
Phase II marker lesion study of 6-week intravesical gemcitabine instillation in patients with low risk non muscle invasive bladder tumours 100
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 99
Frequency, clinical presentation and evolution of renal oncocytomas: Multicentric experience from a European database 98
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 97
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy - A multicenter European study 97
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 96
Significance of tumor size in locally advanced renal cell carcinoma (pT3a): An international multicenter experience 96
CAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers 96
Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options 96
Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas 95
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 95
Effects of the Erbb1/erbb2 Kinase Inhibitor Gw2974 On the Growth and Nse, Chromogranin A and Osteopontin Content of the Androgen-independent Prostate Cancer Cell Line Pc-3 94
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells 94
Endovesical Gemcitabine In Recurrent Previously Treated Non-muscle-invasive Bladder Cancer 93
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility 93
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital 93
Zoledronic Acid Increases the Expression of Ndrg1 Gene In Human Androgen-independent Prostate Cancer Pc3 Cells 92
Prognostic significance of T3A renal cell carcinoma with adrenal gland involvement: An international multicenter experience 92
Docetaxel Retreatment In Docetaxel-pretreated Castration-resistant Prostate Cancer 91
Cigarette Smoking and Drinking Water Source: Correlation with Clinical Features and Pathology of Superficial Bladder Carcinoma 91
Contemporary Management of Non-muscle Invasive Bladder Cancer At Italian Referral Centres Adopting Eau Guidelines 90
Uracyst Enhances the Antitumor Activity of Drugs In Bladder Cancer Cells 89
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016 88
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 87
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 87
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 87
Pca3 Comparison With Prostate Health Index (phi) In Repeat Biopsy Patients 87
Efficacy of one-year maintenance in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer. Results at 24 months of a randomized trial 86
Matrix Metalloproteinase-2 And-9 In the Urine of Prostate Cancer Patients 86
Effects of the antidepressant St. John's wort (hypericum perforatum) on rat and human vas deferens contractility 85
Not traditional prognostic factors in human conventional renal carcinoma. 85
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 84
Drinking water source and cigarette smoking in transitional cell carcinoma of the bladder 83
Distribution of smoking, water resource and other environmental factors in patients affected by superficial bladder cancer 83
Smoking Status, Recurrence Risk and Intravesical Chemotherapy In Non-muscle-invasive Bladder Cancer 80
Low-dose oral chemotherapy for hormone refractory prostate carcinoma (HRPC). Estramustine phosphate versus estramustine phosphate and etoposide. A randomised phase II study of GSTU Foundation 80
Out-patient low-dose oral chemotherapy in hormone refractory prostate carcinoma (HRPC) patients unfit for hospital admittance 80
Npc - A Newer Revolutionary Test For Evaluation of Clinical Series. Bladder Cancer 79
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis 79
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience 78
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content 77
Predictive accuracy of four prognostic models for non-metastatic renal cell carcinoma after nephrectomy: A comparative study. 77
Docetaxel and Carboplatin In Docetaxel Pretreated Castraction-resistant Prostate Cancer: Preliminary Results 77
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder - A study from Gruppo Studi Tumori Urologici (GSTU) Foundation 77
Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer 76
Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases 75
Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: A retrospective study 73
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 71
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis 71
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 70
Local hyperthermia for treatment of advanced prostatic carcinoma: preliminary results. 70
Urotensin Ii Receptor Is Involved In the Regulation of Motility of Prostate Adenocarcinoma Cells and Predicts the Clinical Outcome of Prostate Cancer Patients 67
Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? 66
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 64
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) 55
Totale 12.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022564 0 0 1 6 7 8 12 30 94 86 68 252
2022/2023975 95 55 16 114 137 231 0 101 139 0 65 22
2023/2024343 44 68 16 20 30 32 8 36 1 3 8 77
2024/2025783 23 6 20 27 16 183 108 90 90 26 81 113
2025/20265.789 1.393 1.174 727 111 371 163 648 135 249 329 44 445
2026/2027111 78 33 0 0 0 0 0 0 0 0 0 0
Totale 12.802